Castration-Resistant Prostate Cancer /HRPCA Therapeutics Market
1 Study Coverage
1.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size for the Year 2017-2028
1.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Dynamics
1.4.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Industry Trends
1.4.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Drivers
1.4.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Challenges
1.4.4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Type
2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Segment by Type
2.1.1 Oral Therapy
2.1.2 Injectable Therapy
2.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2017-2028)
2.4 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2017-2028)
3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Application
3.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Segment by Application
3.1.1 Hospitals & Clinics
3.1.2 Home Settings
3.1.3 Ambulatory Surgical Centers (ASCs)
3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2017-2028)
3.4 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2017-2028)
4 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Competitor Landscape by Company
4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Company
4.1.1 Top Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Player (2017-2022)
4.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Concentration Ratio (CR)
4.2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in 2021
4.2.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Headquarters, Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Headquarters and Area Served
4.3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Companies Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Company
4.5.1 Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region
5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas Inc.
7.1.1 Astellas Inc. Company Details
7.1.2 Astellas Inc. Business Overview
7.1.3 Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
7.1.4 Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
7.1.5 Astellas Inc. Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Details
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
7.2.4 Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
7.2.5 Johnson & Johnson Recent Development
7.3 Sanofi S.A
7.3.1 Sanofi S.A Company Details
7.3.2 Sanofi S.A Business Overview
7.3.3 Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
7.3.4 Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
7.3.5 Sanofi S.A Recent Development
7.4 Dendreon Corporation
7.4.1 Dendreon Corporation Company Details
7.4.2 Dendreon Corporation Business Overview
7.4.3 Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
7.4.4 Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
7.4.5 Dendreon Corporation Recent Development
7.5 Bayer AG
7.5.1 Bayer AG Company Details
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
7.5.4 Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
7.5.5 Bayer AG Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Trends
Table 3. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Drivers
Table 4. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Challenges
Table 5. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Restraints
Table 6. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics as of 2021)
Table 15. Top Players of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Astellas Inc. Company Details
Table 31. Astellas Inc. Business Overview
Table 32. Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product
Table 33. Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Astellas Inc. Recent Development
Table 35. Johnson & Johnson Company Details
Table 36. Johnson & Johnson Business Overview
Table 37. Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product
Table 38. Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Johnson & Johnson Recent Development
Table 40. Sanofi S.A Company Details
Table 41. Sanofi S.A Business Overview
Table 42. Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product
Table 43. Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Sanofi S.A Recent Development
Table 45. Dendreon Corporation Company Details
Table 46. Dendreon Corporation Business Overview
Table 47. Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product
Table 48. Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Dendreon Corporation Recent Development
Table 50. Bayer AG Company Details
Table 51. Bayer AG Business Overview
Table 52. Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product
Table 53. Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Bayer AG Recent Development
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
List of Figures
Figure 1. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Picture
Figure 2. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share in Global 2017-2028
Figure 7. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report Years Considered
Figure 8. Product Picture of Oral Therapy
Figure 9. Product Picture of Injectable Therapy
Figure 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type in 2022 & 2028
Figure 11. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2017-2028)
Figure 13. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type in 2022 & 2028
Figure 14. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals & Clinics
Figure 17. Product Picture of Home Settings
Figure 18. Product Picture of Ambulatory Surgical Centers (ASCs)
Figure 19. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application in 2022 & 2028
Figure 20. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2017-2028)
Figure 22. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application in 2022 & 2028
Figure 23. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2017-2028)
Figure 25. North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Astellas Inc. Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
Figure 55. Sanofi S.A Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
Figure 56. Dendreon Corporation Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
Figure 57. Bayer AG Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Industry Market Size
